Article
Studies show potential problems, but many questions remain unanswered
Telomir-1 exhibited strong ROS reduction properties, hold potential for AMD treatment
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Retinal detachment risk after B1KPro
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Sexual harassment remains high in ophthalmology
Heart Eye announces AI-driven retinal imaging system to detect biomarkers of cardiovascular health risks
